Free Trial
→ The next assassination attempt won’t be on Trump (From Porter & Company) (Ad) Free USAQ Stock Alerts

QHSLab (USAQ) Short Interest Ratio & Short Volume

QHSLab logo
$0.09 0.00 (0.00%)
(As of 11/14/2024 ET)
Compare

QHSLab Short Interest Data

QHSLab (USAQ) has a short interest of 1,300 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1,531 shares to cover all short positions.

Current Short Interest
1,300 shares
Previous Short Interest
1,300 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$131.30
Short Interest Ratio
0.2 Days to Cover
Last Record Date
September 15, 2024
Outstanding Shares
10,220,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
0 shares
Average Trading Volume
1,531 shares
Today's Volume Vs. Average
0%
Short Selling QHSLab?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for QHSLab and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

USAQ Short Interest Over Time

USAQ Days to Cover Over Time

USAQ Percentage of Float Shorted Over Time

QHSLab Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20241,300 shares $131.30 No ChangeN/A0.2 $0.10
8/31/20241,300 shares $194.35 +1,200.0%N/A0.1 $0.15
8/15/2024100 shares $16.00 No ChangeN/A0 $0.16
7/31/2024100 shares $21.00 -96.0%N/A0 $0.21
7/15/20242,500 shares $593.75 +257.1%N/A0.3 $0.24
6/30/2024700 shares $170.80 -12.5%N/A0.1 $0.24
6/15/2024800 shares $200.00 No ChangeN/A0.3 $0.25
5/31/2024800 shares $144.00 No ChangeN/A0 $0.18
4/30/2024100 shares $11.95 -88.9%N/A0 $0.12
4/15/2024900 shares $88.16 -91.2%N/A0.1 $0.10
3/31/202410,200 shares $886.38 -56.0%N/A0.2 $0.09
3/15/202423,200 shares $1,160.00 +11,500.0%N/A0.3 $0.05
2/29/2024200 shares $24.00 -60.0%N/A0 $0.12
2/15/2024500 shares $40.00 -97.3%N/A0.1 $0.08
1/15/202413,800 shares $565.80 -13.2%N/A23 $0.04
12/31/202315,900 shares $1,431.00 +329.7%N/A0.7 $0.09
12/15/20233,700 shares $111.00 +3,600.0%N/A0.3 $0.03
11/30/2023100 shares $3.40 -98.7%N/A0 $0.03
11/15/20237,700 shares $269.50 -11.5%N/A0.9 $0.04
10/31/20238,700 shares $265.35 -33.6%N/A0.2 $0.03
10/15/202313,100 shares $917.00 No ChangeN/A0.5 $0.07
5/15/2023500 shares $55.00 +400.0%N/A0.1 $0.11
4/30/2023100 shares $11.16 No ChangeN/A0.1 $0.11
4/15/2023100 shares $11.00 No ChangeN/A0 $0.11
3/31/2023100 shares $14.90 No ChangeN/A0.1 $0.15
3/15/2023100 shares $15.63 -50.0%N/A0 $0.16
2/28/2023200 shares $34.00 -66.7%N/A0 $0.17
2/15/2023600 shares $90.00 +200.0%N/A0.3 $0.15
1/31/2023200 shares $32.15 No ChangeN/A0 $0.16
1/15/2023200 shares $32.00 No ChangeN/A0.7 $0.16
12/30/2022200 shares $32.80 No ChangeN/A0 $0.16
12/15/2022200 shares $33.00 No ChangeN/A0.1 $0.17
11/30/2022200 shares $31.20 No ChangeN/A0.1 $0.16
11/15/2022200 shares $31.60 -50.0%N/A0.1 $0.16
10/31/2022400 shares $71.96 No ChangeN/A0.3 $0.18
10/15/2022400 shares $63.20 -92.2%N/A0 $0.16
9/30/20225,100 shares $917.49 +363.6%N/A1 $0.18
9/15/20221,100 shares $198.14 -86.4%N/A0.1 $0.18
8/31/20228,100 shares $1,470.96 +636.4%N/A0.4 $0.18
8/15/20221,100 shares $231.00 No ChangeN/A0 $0.21
Nvidia’s world of pain awaits (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Click play to stream The Final Frontier at no cost
7/31/20221,100 shares $275.00 No ChangeN/A0.1 $0.25
7/15/20221,100 shares $440.00 -50.0%N/A3.7 $0.40
6/30/20222,200 shares $748.00 +100.0%N/A4.4 $0.34
6/15/20221,100 shares $440.00 No ChangeN/A1.4 $0.40
5/31/20221,100 shares $440.17 -65.6%N/A0.2 $0.40
5/15/20223,200 shares $1,568.00 +77.8%N/A0.2 $0.49
4/30/20221,800 shares $936.00 +12.5%N/A0.9 $0.52
4/15/20221,600 shares $847.84 -27.3%N/A0.9 $0.53
3/31/20222,200 shares $1,210.00 -35.3%N/A4.4 $0.55
3/15/20223,400 shares $2,040.00 -10.5%N/A3.4 $0.60
2/28/20223,800 shares $1,710.00 +5.6%N/A0.6 $0.45
2/15/20223,600 shares $2,106.00 +38.5%N/A2.1 $0.59
1/31/20222,600 shares $1,560.00 +8.3%N/A1.4 $0.60
1/15/20222,400 shares $1,464.00 No ChangeN/A0.6 $0.61
12/31/20212,400 shares $1,752.00 +41.2%N/A0.2 $0.73
12/15/20211,700 shares $858.50 No ChangeN/A0.3 $0.51
11/30/20211,700 shares $1,096.50 No ChangeN/A0.3 $0.65
11/15/20211,700 shares $1,270.75 No ChangeN/A0.9 $0.75
10/29/20211,700 shares $1,190.00 -50.0%N/A0.4 $0.70
10/15/20213,400 shares $2,210.00 -2.9%N/A0.7 $0.65
9/30/20213,500 shares $2,520.00 +2.9%N/A0.5 $0.72
9/15/20213,400 shares $2,652.00 No ChangeN/A0.6 $0.78
8/31/20213,400 shares $2,618.00 -5.6%N/A0.5 $0.77
8/13/20213,600 shares $2,916.00 No ChangeN/A0.6 $0.81
7/30/20213,600 shares $2,880.00 +44.0%N/A0.3 $0.80
7/15/20212,500 shares $2,225.00 +2,400.0%N/A0.1 $0.89
6/30/2021100 shares $68.00 -96.0%N/A0 $0.68
6/15/20212,500 shares $1,762.50 +56.3%N/A0.3 $0.71
5/28/20211,600 shares $1,096.00 +6.7%N/A0.5 $0.69
5/14/20211,500 shares $945.00 -46.4%N/A0.3 $0.63
4/30/20212,800 shares $1,624.00 -56.9%N/A0.4 $0.58
4/15/20216,500 shares $4,225.00 +6,400.0%N/A0.4 $0.65
3/31/2021100 shares $60.00 No ChangeN/A0 $0.60
2/26/20211,000 shares $620.00 -37.5%N/A0.1 $0.62
2/12/20211,600 shares $1,040.00 +1,500.0%N/A0.3 $0.65
1/29/2021100 shares $61.00 No ChangeN/A0 $0.61
1/15/2021200 shares $102.00 No ChangeN/A0 $0.51
12/31/2020200 shares $104.00 No ChangeN/A0 $0.52
12/15/2020200 shares $110.00 No ChangeN/A0 $0.55
11/30/2020200 shares $110.00 -60.0%N/A0 $0.55
10/30/2020700 shares $441.00 -85.4%N/A0.1 $0.63
10/15/20204,800 shares $0.00 +433.3%N/A0.7 $0.00

USAQ Short Interest - Frequently Asked Questions

What is QHSLab's current short interest?

Short interest is the volume of QHSLab shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 1,300 shares of USAQ short. Learn More on QHSLab's current short interest.

How does QHSLab's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "medical equipment" compare to QHSLab: Aethlon Medical, Inc. (2.05%), Predictive Oncology Inc. (2.29%), ENDRA Life Sciences Inc. (4.63%), Nuwellis, Inc. (29.58%), Venus Concept Inc. (35.11%), Quoin Pharmaceuticals, Ltd. (9.47%), Heart Test Laboratories, Inc. (2.83%), Vycor Medical, Inc. (0.00%), Bluejay Diagnostics, Inc. (0.13%), Sintx Technologies, Inc. (4.98%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short QHSLab stock?

Short selling USAQ is an investing strategy that aims to generate trading profit from QHSLab as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against QHSLab?

A short squeeze for QHSLab occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of USAQ, which in turn drives the price of the stock up even further.

How often is QHSLab's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including USAQ, twice per month. The most recent reporting period available is September, 15 2024.



Related Companies
Short Interest Tools

This page (OTCMKTS:USAQ) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners
Central Bank Abandons USD
Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...
True Gold Republic | Sponsored
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
Musk Says ‘Dollar Will Be Worth Nothing…’
Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...
Crypto 101 Media | Sponsored
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...
Colonial Metals | Sponsored
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...
Crypto Swap Profits | Sponsored
Crypto’s next big bull run?
Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...
Weiss Ratings | Sponsored
Elon Musk has put himself in their crosshairs
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...
Porter & Company | Sponsored
Trump Win = "Bull Trap"?
Dan's research shows that the last time the market looked this way, not only did our economy suffer a large su...
Stansberry Research | Sponsored